Cheng Andrew (CIK 1778307) reported 38 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Sell AKRO (277,075 shares), Sell AKRO (159,762 shares), Sell AKRO (74,538 shares), Sell AKRO (14,739 shares), Buy AKRO (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 277,075 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 159,762 | $0 |
| 2025-11-21 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 74,538 | $0 |
| 2025-11-13 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 14,739 | $0 |
| 2025-10-14 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Buy | 30,000 | $596,100 |
| 2025-10-14 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 30,000 | $1.6M |
| 2025-10-09 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Buy | 52,212 | $32,371 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 1,796 | $77,264 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Buy | 1,919 | $38,131 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 22,525 | $968,350 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 7,317 | $321,948 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 158 | $7,050 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Buy | 13,022 | $82,820 |
| 2025-08-13 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 10,795 | $518,916 |
| 2025-08-13 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 18,805 | $919,000 |
| 2025-08-13 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 400 | $19,776 |
| 2025-07-11 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 14,686 | $742,671 |
| 2025-07-11 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 15,314 | $792,193 |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Buy | 890 | $21,244 |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 6,620 | $363,041 |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 14,842 | $797,906 |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 15,158 | $823,837 |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 7,837 | $423,120 |
| 2025-05-13 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 7,200 | $295,200 |
| 2025-05-13 | Akero Therapeutics, Inc. (AKRO) | President and CEO | Sell | 22,800 | $949,164 |
Source: SEC Form 4 filings · as of 2025-12-09